InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,576.98
(
0.07%
)
US TECH 100
19,930.80
(
0.19%
)
Dow Jones
39,291.97
(
-0.13%
)
Brent Oil
84.39
(
-0.37%
)
Bitcoin
57,909.28
(
-0.19%
)
Post# of 426632
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Number sleven

Send PM Follow Ignore
Followers 35
Posts 6841
Boards Moderated 1
Alias Born 04/04/2020

Number sleven

Re: oneragman post# 366696

Tuesday, 01/18/2022 7:56:50 PM

Tuesday, January 18, 2022 7:56:50 PM

Post# of 426632
One, I think you misunderstood the point of my post. Vascepa is a drug with a very limited API supply. Once Amarin is a profitable company, in non US markets, Amarin could cut off US supply. How do you think that would go over. Activist judges and politicians would need to rethink a few things. I saw the chat. I am not concerned. Vascepa will be a commercial success. CVD is a disease that requires treatment. Vascepa is the logical option. I don't think a buy out is necessary.
Sleven,
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Start posting your company's news
Only $200 per official company press release!